Changing the Business Model: Drawing on Global Examples of Innovation to Find New Products and Maximize Efficiency

 

Biopharma executives from around the world will gather in Paris to discuss and debate new ways of sourcing, developing and marketing innovation.

 
Featuring the leading strategic minds in the industry, one-on-one meetings and networking opportunities, and presentations from the most promising companies - all at the elegant Hilton Arc de Triomphe Paris.

 

The 19th Annual Euro-Biotech Partnering Summit draws on global examples of innovative methods to find new products efficiently and effectively, and to ensure their potential is maximized through novel and creative strategies. This global forum will combine innovative company presentations, one-on-one partnering, and dynamic content discussions, including "Creative R&D: Sourcing Innovation and New Business Models," and "Preparing to Outlicense: How to be Market Ready".

• 2012 Sponsors/Partners
• 2011 Attending Companies
• Photos
• Future Conferences

Hear Biopharma Leaders’ First-Hand Perspectives on:    • M&A    • Dealmaking trends    • Alliance structures    • Deal terms    • Company valuation    • Deal re-negotiation    • European marketing rights    • European spec pharma issues    • Options-based deals    • Reimbursement    • Biotech financing    • Biotech exit strategies    • R&D models

In this economic climate, pharmaceutical companies are under more pressure than ever before to innovate, develop their pipeline and bring new products to market.   Euro-Biotech Partnering Summit is the premier partnering forum for companies interested in research collaboration and licensing arrangements and brings together companies offering these high-value assets that your future sales demand – plus, you’ll also meet the companies who are looking for exactly the assets you have to offer. The most active in-licensors and out-licensors will all be on hand to create future growth through investments in partnership deals.

 

The Euro-Biotech Partnering Summit proprietary partnering system enables attendees to meet one-on-one with other key decision-makers and network with their peers for a more personal experience in an intimate setting. 

 

Pre-meeting - attendees can identify, research and set up meetings with prospective partners by utilizing the partnering database - searchable criteria includes:

• Company and delegate profiles as well as licensing opportunities provided by attendees themselves
• More than 22 therapeutic categories including cardiovascular, oncology, CNS and more
• Products or technologies
• Phase of project market type (specialty or general)
• Geographic marketing rights desired .
• Molecule type (small molecule, protein, antibody, peptide, or other macromolecule)
• Mode of administration

**Plus
Each company profile on the Euro-Biotech Partnering Summit software is linked with Elsevier’s Strategic Transactions and IN VIVO articles database. Strategic Transactions delivers the most comprehensive deals and tech transfer data in the industry, including alliances, financings and M&As across biopharmaceuticals, devices and diagnostics. It is the only deals database featuring available, hyperlinked analysis from Elsevier’s expert editorial team, plus available links to Inteleos, Elsevier’s extensive drug pipeline database.